Oncology Pharma Inc.
ONPH · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $13,056 | $16,502 | $49,632 | $5,000 |
| - Cash | $0 | $2 | $1 | $43 |
| + Debt | $778 | $773 | $690 | $290 |
| Enterprise Value | $13,833 | $17,273 | $50,320 | $5,247 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$83 | -$10 | -$81 |
| % Margin | – | – | – | – |
| Net Income | -$255 | -$5,319 | -$24 | -$81 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.007 | -0.15 | -0.001 | -40,500 |
| % Growth | 95.6% | -21,328.6% | 100% | – |
| Operating Cash Flow | -$2 | -$4 | $17 | -$81 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$4 | $17 | -$81 |